SCHEMBL24401430

SCHEMBL24401430

O=c1c2ccccc2sc2cc3c(cc12)C1(c2ccccc2-c2cc(-n4c5ccccc5c5ccccc54)ccc21)c1ccccc1-3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 5/20 0.36
MAPT P10636 5/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
RAB9A P51151 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 2/20 0.36
POLB P06746 2/20 0.34
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
ATM Q13315 1/20 0.31
HPGD P15428 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
HCRTR1 O43613 2/20 0.30
MEN1 O00255 1/20 0.30
NFKB1 P19838 1/20 0.30
NFKB2 Q00653 1/20 0.30
KMT2A Q03164 1/20 0.30
RELA Q04206 1/20 0.30
DUSP3 P51452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24401409 0.96 KDM4E (0.38) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL24401662 0.86 KDM4E (0.37) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL24401599 0.86 KDM4E (0.49) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL24401415 0.86 MAPT (0.34) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL24401659 0.85 KDM4E (0.38) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL24401414 0.84 PMM2 (0.34) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL16373499 0.81 L3MBTL1 (0.33) KDM4EALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL22928199 0.81 KDM4E (0.46) KDM4EALDH1A1MAPTL3MBTL1POLB
SCHEMBL12685494 0.81 KDM4E (0.46) KDM4EALDH1A1MAPTL3MBTL1POLB
SCHEMBL15087891 0.81 KDM4E (0.46) KDM4EALDH1A1MAPTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CDYL, MRPL38, CDYL2 KDM4E 3526/4885ALDH1A1 1697/4885MAPT 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.